Cost effectiveness of gentamicin and tobramycin.
D003362:Cost-Benefit Analysis; D005839:Gentamicins / Q000009:adverse effects*; D006801:Humans; D007674:Kidney Diseases / Q000191:economics*; D006435:Renal Dialysis / Q000191:economics*; D014031:Tobramycin / Q000009:adverse effects*
D005839:Gentamicins; D014031:Tobramycin